IGF-I and not IGF-II expression is regulated by glucocorticoids in human fetal epiphyseal chondrocytes

Growth Hormone and IGF Research

Volumn 18, Issue 6, 2008, Pages 497-505

  Fernandez Cancio, M ^a   Esteban, C ^a   Carrascosa, A ^a   Toran, N ^a   Andaluz, P ^a   Audi, L ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Dexamethasone; Gene expression; Human growth plate chondrocytes; IGF I; Mifepristone

Indexed keywords

AGGRECAN; COLLAGEN TYPE 2; DEXAMETHASONE; GLUCOCORTICOID; GROWTH HORMONE RECEPTOR; MIFEPRISTONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR SOX9;

ARTICLE; CARTILAGE CELL; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; EPIPHYSEAL CARTILAGE; FEMALE; FETUS; GENE EXPRESSION; HORMONE ACTION; HORMONE INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

CELLS, CULTURED; CHONDROCYTES; DEXAMETHASONE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GROWTH PLATE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIFEPRISTONE;

EID: 53349172123     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.04.004     Document Type: Article

References (55)

1. Allen D.B. Growth suppression by glucocorticoid therapy. Endocrinol. Metab. Clin. North Am. 25 (1996) 699-717
2. Bello C.E., and Garrett S.D. Therapeutic issues in oral glucocorticoid use. Lippincotts Prim. Care Pract. 3 (1999) 333-341
3. Price W.A., Stiles A.D., Moats-Staats B.M., and D'Ercole A.J. Gene expression of insulin-like growth factors (IGFs) the type 1 IGF receptor and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 130 (1992) 1424-1432
4. Leili S., and Scanes C.G. The effects of glucocorticoids (dexamethasone) on insulin-like growth factor-I, IGF-binding proteins, and growth in chickens. Proc. Soc. Exp. Biol. Med. 218 (1998) 329-333
5. Rooman R., Koster G., Bloemen R., Gresnigt R., and van Buul-Offers S.C. The effect of dexamethasone on body and organ growth of normal and IGF-II transgenic mice. J. Endocrinol. 163 (1999) 543-552
6. Stevens D., and Williams G.R. Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol. Cell. Endocrinol. 151 (1999) 195-204
7. Silvestrini G., Ballanti P., Patacchioli F.R., Mocetti P., Di Grezia R., Wedard B.M., Angelucci L., and Bonucci E. Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone. Bone 26 (2000) 33-42
8. Baron J., Huang Z., Oerter K.E., Bacher J.D., and Cutler Jr. G.C. Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. Am. J. Physiol. 263 (1992) E489-E492
9. Jux C., Leiber K., Hugel U., Blum W., Ohlsson C., Klaus G., and Mehls O. Dexamethasone impairs growth hormone (GH)-stimulated growth by suppression of local insulin-like growth factor (IGF)-I production and expression of GH- and IGF-I-receptor in cultured rat chondrocytes. Endocrinology 139 (1998) 3296-3305
10. Klaus G., Jux C., Fernandez P., Rodriguez J., Himmele R., and Mehls O. Supression of growth plate chondrocyte proliferation by corticosteriods. Pediatr. Nephrol. 14 (2000) 612-615
11. Koedam J.A., Hoogerbrugge C.M., and van Buul-Offers S.C. Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone. J. Endocrinol. 165 (2000) 557-567
12. Smink J.J., Koedam J.A., Koster J.G., and van Buul-Offers S.C. Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components. J. Endocrinol. 174 (2002) 343-352
13. Baker J., Liu J.P., Robertson E.J., and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 (1993) 73-82
14. Woods K.A., Camacho-Hubner C., Savage M.O., and Clark A.J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N. Engl. J. Med. 335 (1996) 1363-1367
15. Murphy V.E., Smith R., Gles W.B., and Clifton V.L. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr. Rev. 27 (2006) 141-169
16. Bhaumick B. Insulin-like growth factor (IGF) binding proteins and insulin-like growth factor secretion by cultured chondrocyte cells: identification, characterization and ontogeny during cell differentiation. Regul. Pept. 48 (1993) 113-122
17. Olney R.C., and Mougey E.B. Expression of the components of the insulin-like growth factor axis across the growth-plate. Mol. Cell. Endocrinol. 156 (1999) 63-71
18. Parker E.A., Hegde A., Buckley M., Barnes K.M., Baron J., and Nilsson O. Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage. J. Endocrinol. 194 (2007) 31-40
19. Nilsson A., Carlsson B., Isgaard J., Isaksson O.G., and Rymo L. Regulation by GH of insulin-like growth factor-I mRNA expression in rat epiphyseal growth plate as studied with in-situ hybridization. J. Endocrinol. 125 (1990) 67-74
20. Shinar D.M., Endo N., Halperin D., Rodan G.A., and Weinreb M. Differential expression of insulin-like growth factor-I (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 132 (1993) 1158-1167
21. Wang E., Wang J., Chin E., Zhou J., and Bondy C.A. Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis. Endocrinology 136 (1995) 2741-2751
22. De los Rios P., and Hill D.J. Cellular localization and expression of insulin-like growth factors (IGFs) and IGF binding proteins within the epiphyseal growth plate of the ovine fetus: possible functional implications. Can. J. Physiol. Pharmacol. 77 (1999) 235-249
23. Reinecke M., Schmid A.C., Heyberger-Meyer B., Hunziker E.B., and Zapf J. Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 141 (2000) 2847-2853
24. Carrascosa A., Audi L., and Ballabriga A. Morphologic and metabolic development of human fetal epiphyseal chondrocytes in primary culture. Pediatr. Res. 19 (1985) 720-727
25. Carrascosa A., Audi L., Fernandez M.A., and Ballabriga A. Biological effects of androgens and identification of specific dihydrotestosterone-binding sites in cultured human fetal epiphyseal chondrocytes. J. Clin. Endocrinol. Metab. 70 (1990) 134-140
26. Carrascosa A., Fernandez M.A., Audi L., and Ballabriga A. Effects of triiodothyronine (T3) and identification of specific nuclear T3-binding sites in cultured human fetal epiphyseal chondrocytes. J. Clin. Endocrinol. Metab. 75 (1992) 140-144
27. Fernandez M.A., Carrascosa A., Audi L., and Ballabriga A. Somatostatin effects on cultured human fetal epiphyseal chondrocytes. Pediatr. Res. 32 (1992) 571-573
28. Garcia-Ramirez M., Audi L., Andaluz P., and Carrascosa A. Effects of TGF-beta1 on proliferation and IGFBP-3 production in a primary culture of human fetal epiphyseal chondrocytes (HFEC). J. Clin. Endocrinol. Metab. 84 (1999) 2978-2981
29. Garcia-Ramirez M., Toran N., Andaluz P., Carrascosa A., and Audi L. Vascular endothelial growth factor is expressed in human fetal growth cartilage. J. Bone Miner. Res. 15 (2000) 534-540
30. LeRoith D., Bondy C., Yakar S., Liu J.L., and Butler A. The somatomedin hypothesis: 2001. Endocr. Rev. 22 (2001) 53-74
31. Luo J.M., and Murphy L.J. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 125 (1989) 165-171
32. Smink J.J., Koster J.G., Gresnigt M.G., Rooman R., Koedam J.A., and van Buul-Offers S.C. IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice. J. Endocrinol. 175 (2002) 143-153
33. Lin W.W., and Oberbauer A.M. Spatiotemporal expression of alternatively spliced IGF-I mRNA in the rat costochondral growth plate. J. Endocrinol. 160 (1999) 461-467
34. Han V.K.M., D'Ercole A.J., and Lund P.K. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236 (1987) 193-197
35. Hill D.J., Clemmons D.R., Wilson S., Han V.K., Strain A.J., and Milner R.D. Immunological distribution of one form of insulin-like growth factor (IGF)-binding protein and IGF peptides in human fetal tissues. J. Mol. Endocrinol. 2 (1989) 31-38
36. Mushtaq T., Farquharson C., Seawright E., and Ahmed S.F. Glucocorticoid effects on chondrogenesis, differentiation and apoptosis in the murine ATDC5 chondrocyte cell line. J. Endocrinol. 175 (2002) 705-713
37. Olney R.C., Wang J., Sylvester J.E., and Mougey E.B. Growth factor regulation of human growth plate chondrocyte proliferation in vitro. Biochem. Biophys. Res. Commun. 317 (2004) 1171-1182
38. Kiepe D., Ulinski T., Powell D.R., Durham S.K., Mehls O., and Tönshoff B. Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. Kidney Int. 62 (2002) 1591-1600
39. Carrascosa A., and Audi L. Human studies on the biological actions of IGF-1. Evidence suggesting that human fetal and postnatal epiphyseal cartilage is a target tissue for IGF-1 action. J. Pediatr. Endocrinol. 6 (1993) 257-261
40. Matsumoto T., Tsurumoto T., Goldring M.B., and Shindo H. Differential effects of IGF-binding proteins, IGFBP-3 and IGFBP-5, on IGF-I action and binding to cell membranes of immortalized human chondrocytes. J. Endocrinol. 166 (2000) 29-37
41. Cheng S.L., Zhang S.F., Mohan S., Lecanda F., Fausto A., Hunt A.H., Canalis E., and Avioli L.V. Regulation of insulin-like growth factors I and II and their binding proteins in human bone marrow stromal cells by dexamethasone. J. Cell. Biochem. 71 (1998) 449-458
42. Delany A.M., and Canalis E. Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology 136 (1995) 4776-4781
43. Okazaki R., Riggs B.L., and Conover C.A. Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells. Endocrinology 134 (1994) 126-132
44. Villafuerte B.C., Koop B.L., Pao C.I., and Phillips L.S. Glucocorticoid regulation of insulin-like growth factor-binding protein-3. Endocrinology 136 (1995) 1928-1933
45. DiBattista J.A., Dore S., Morin N., and Abribat T. Prostaglandin E2 up-regulates insulin-like growth factor binding protein-3 expression and synthesis in human articular chondrocytes by a c-AMP-independent pathway: role of calcium and protein kinase A and C. J. Cell. Biochem. 63 (1996) 320-333
46. McCarthy T.L., Ji C., Chen Y., Kim K., and Centrella M. Time-and dose-related interactions between glucocorticoid and cyclic adenosine 3′,5′-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts. Endocrinology 141 (2000) 127-137
47. Delany A.M., Durant D., and Canalis E. Glucocorticoid suppression of IGF I transcription in osteoblasts. Mol. Endocrinol. 15 (2001) 1781-1789
48. Heinrichs C., Yanovski J.A., Roth A.H., Yu Y.M., Domene H.M., Yano K., Cutler Jr. G.B., and Baron J. Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate. Endocrinology 135 (1994) 1113-1118
49. Sekiya I., Koopman P., Tsuji K., Mertin S., Harley V., Yamada Y., Shinomiya K., Nifuji A., and Noda M. Dexamethasone enhances SOX9 expression in chondrocytes. J. Endocrinol. 169 (2001) 573-579
50. de Crombrugghe B., Lefebvre V., Behringer R.R., Bi W., Murakami S., and Huang W. Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol. 19 (2000) 389-394
51. Zhou G., Garofalo S., Mukhopadhyay K., Lefebvre V., Smith C.N., Eberspaecher H., and de Crombrugghe B. A 182 bp fragment of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte expression in transgenic mice. J. Cell. Sci. 108 (1995) 3677-3684
52. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., Nifuji A., and Noda M. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J. Biol. Chem. 275 (2000) 10738-10744
53. Clayton P.E., Miller W.L., Oberfield S.E., Ritzen E.M., Sippell W.G., and Speiser P.W. ESPE/LWPES CAH Working Group, Consensus statement on 21-hydroxylase deficiency from European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. Horm. Res. 58 (2002) 188-195
54. Joint LWPES/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society. J. Clin. Endocrinol. Metab. 87 (2002) 4048-4053
55. Lajic S., Nordenström A., Ritzen E.M., and Wedell A. Prenatal treatment of congenital adrenal hyperplasia. Eur. J. Endocrinol. 151 (2004) U63-U69